Does it not concern you the findings from an unrelated party undermines PARs objective to obtain further IP?
serious question. Because if you look at the back and forth with the patent office on PARs submitted patents, I am.
- Forums
- ASX - By Stock
- PAR
- iPPS and Long Covid, but first a Prologue & story...
iPPS and Long Covid, but first a Prologue & story..., page-11
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 22.0¢ | $34.69K | 154.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 0.225 |
7 | 211158 | 0.220 |
10 | 205052 | 0.215 |
12 | 169584 | 0.210 |
8 | 175200 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 25000 | 1 |
0.235 | 42540 | 3 |
0.240 | 93500 | 3 |
0.245 | 1000 | 1 |
0.250 | 89857 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online